Company In-Depth View

IndiGo: Near term outlook to be tough; weak demand, higher costs to weigh

Coal India's volumes fail to pick up in May, earnings likely to decline

New launches, cost-control efforts, margin improvement crucial for Lupin

Retailers to gain from easier norms, recovery longer for malls, multiplexes

Godrej Consumer will have to deliver on volumes for valuations to sustain

Specialty products segment key to Sun Pharma's growth prospects

ABFRL: Multiple headwinds likely in near term, investors advised caution

Dabur posts weak show in March quarter; investors eye rural success

JSPL's all-round show in Q4 leaves investors happy, analysts maintain 'buy'

JSPL's all-round show in Q4 leaves investors happy, analysts maintain 'buy'

JSPL's all-round beat in Q4 leaves investors happy; stock rises over 13%

Bata: Despite subdued Q4, hope of faster recovery may keep sentiment intact

GSK Pharma: Near term headwinds may keep stock prices under pressure

Crompton Consumer: Cost control, market share gains lend comfort

Why ITC's Sunrise Foods deal is positive but unlikely to push up valuation

Dmart stock to hit margin roadblock: Low footfall, high cost to dent profit

Despite dull business, downside limited for Hindustan Zinc stock

'Polarised' and 'sell on rally' may define markets' character, say experts

Q4 a minor blip in Biocon's growth story, recovery expected in Q1FY21

Colgate: Q4 shows non-Covid pain still high, market share recovery may drag

Next